In August 2026, the FIP Council approved updated guidelines designed to support FIP member organisations and relevant national stakeholders – including regulatory authorities, professional bodies and educational institutions – in the development, updating and implementation of their codes of ethics for pharmacists.

This joint digital event organised by the FIP and the International Conference of Francophone Chambers of Pharmacists (CIOPF) will present the FIP’s policy statement as well as experiences from various countries within the Francophone world.

En août 2026, le Conseil de la FIP a approuvé des lignes directrices actualisées visant à accompagner les organisations membres de la FIP et les parties prenantes nationales concernées, notamment les autorités de régulation, les organismes professionnels et les établissements de formation, dans l'élaboration, la mise à jour et la mise en œuvre de leur code de déontologie pour les pharmaciens.

Cet événement numérique conjoint de la FIP et de la Conférence Internationale des Ordres de Pharmaciens Francophones (CIOPF) présentera la déclaration politique de la FIP ainsi que des expériences issues de différents pays de l’espace francophone.

Moderator:
-Luís Lourenço, FIP vice president, Portugal.
-Dr Alain Delgutte, Treasurer, French chamber of pharmacists / CIOPF, France.

Panellists:
-Dr Nyasenu Tufa, Président, Ordre des pharmaciens du Togo, Togo.
-Henriette Vanga Bosson, Vice-présidente, Conseil national Ordre des pharmaciens de Côte d’Ivoire, Côte d’Ivoire.
-Dr Laroussi Mustapha, Président, Conseil national de l’Ordre des pharmaciens de Tunisie, Tunisie.
-Prof. Betty B. Chaar, The University of Sydney School of Pharmacy, Australia.

*Please note that the event will be in French and a Zoom account is required to register for this FIP Digital Event. If you are receiving an error message during registration, please create a Zoom account and use the corresponding email address for your registration.

FIP Online Antimicrobial Resistance (AMR) Summit: From commitment to action: Strengthening collaboration through regional & global engagement will bring together pharmacists, pharmacy organisations, healthcare professionals and other stakeholders to explore how FIP AMR Declaration can be translated into coordinated action at regional, national and local levels. The summit will highlight progress, experiences and practical approaches from different regions, with a focus on strengthening collaboration, sharing good practices and accelerating the implementation of antimicrobial stewardship and other pharmacy-led actions to address AMR.

Co-Chair:
-Prof. Tracey Thornley, AMR commission member ,Chair of FIP data & intelligence, UK.
-Dr Dalal Hammoudi Halat, AMR Commission member, FIP, Qatar.
-Dr Cristina Fernández Barrantes, AMR commission member, FIP, Costa Rica.

Panellists:
-Dr Catherine Duggan, FIP Chief executive officer, The Netherlands.
-Dr Michiyo Kawana, Executive director, Japan pharmaceutical association, Japan.
-Dr Elki Sollenbring, Pharmacist, Costa Rican college of pharmacists, San José, Costa Rica.

*Please note that a Zoom account is required to register for this FIP Digital Event. If you are receiving an error message during registration, please create a Zoom account and use the corresponding email address for your registration.

Healthcare training has traditionally happened in professional silos, yet strong evidence shows that interprofessional collaborative practice (IPCP) improves quality, coordination and health outcomes. This webinar explores the state of interprofessional education (IPE) across the Americas, the barriers institutions face at educational, institutional and systemic levels, and strategies to build sustainable IPE programmes. Participants will also be introduced to the FIP Interprofessional Education Readiness Tool, a self-assessment instrument designed to help institutions identify gaps, benchmark progress internationally and strengthen collaborative practice-ready training for future health professionals.

Moderator:
-Prof. Silvana Leite, Professor, Universidade Federal de Santa Catarina, Brazil.

Co-moderator:
-Prof. Peter Swaan, Professor and Dean, University of Florida, USA.

Guests:
-Dr Jennifer Lake, Assistant professor (Teaching), Leslie dan faculty of pharmacy, University of Toronto, Canada.
-Prof. Wanda Maldonado, Dean, University of Puerto Rico, Puerto Rico.
-Dr Elena M. Umland, Dean and professor, Albany college of pharmacy and health sciences, USA.

Facilitator:
-Dr Genuine Desireh, FIP UNITWIN and Provision Programme Manager, The Netherlands.

*Please note that a Zoom account is required to register for this FIP Digital Event. If you are receiving an error message during registration, please create a Zoom account and use the corresponding email address for your registration.

FIP is hosting a digital event exploring how pharmacists and pharmacy teams can contribute to more person-centred, inclusive and responsive mental health care. Bringing together perspectives from global mental health, patient advocacy and pharmacy, the event will consider how people can be meaningfully involved in shaping mental health care, how community-based approaches can strengthen access and continuity of care, and how pharmacists and pharmacy teams can support more accessible and person-centred mental health services.

Moderator:
-Raquel Martinez Garcia, Secretary general of the general pharmaceutical council of Spain, Spain.

Panellists:
-Dr Mark van Ommeren, Head, WHO Mental health and substance use, Switzerland.
-Andrew Spiegel, Board chair, World patients alliance, US based but global organization.
-Rita de la Plaza, Treasurer of the general pharmaceutical council of Spain, Spain.

*Please note that a Zoom account is required to register for this FIP Digital Event. If you are receiving an error message during registration, please create a Zoom account and use the corresponding email address for your registration.

The increasing globalization of drug development has expanded the use of multiregional clinical trials (MRCTs) to support global development and generate clinical evidence across diverse patient populations. However, differences in regulatory frameworks, health authority expectations, and country- and region-specific requirements introduce complexity into MRCT planning and conduct. An early global regulatory strategy is therefore critical to identify requirements and anticipate key challenges.

Moderator:
-Dr Mathew Cherian, Consultant, USA.

Co-moderator:
-Dr Richard Ohene-Darkoh, Pharmaceutical country manager, Liberia.

Panellist:
-Dr Ana Cruz, Regulatory affairs manager, Clinical research, Thermo Fisher (PPD Portugal), Lisboa, Portugal.

*Please note that a Zoom account is required to register for this FIP Digital Event. If you are receiving an error message during registration, please create a Zoom account and use the corresponding email address for your registration.